WHO approval of Chinese vaccine will accelerate Covax supply: analysts


BEIJING (Global Times): The WHO's emergency approval of China's Covid-19 vaccine will boost global vaccine supply amid shortfall as China's overall yearly production capacity is approaching five billion doses, observers said.

The WHO gave Emergency Use Listing (EUL) to Sinopharm's Covid-19 vaccine on Friday (May 7) afternoon, making it the sixth vaccine and the first made by a non-Western country to receive WHO validation for its safety, efficacy and quality.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

China , Covax , vaccine , supply , WHO , approval

   

Next In Aseanplus News

Mt Ruang eruption damages thousands of houses in North Sulawesi
Thailand plans for first post-coup Senate election, referendum
Bella Astillah has long known Sarah Yasmine is one of 11 women in relationship with husband Aliff Aziz
‘Audio deepfake’ of Marcos ordering military action against China prompts Manila to debunk clip
Singapore firms rethink workplace policies ahead of new flexi-work guidelines
Traditional Vietnamese ceremony honours ancient Hoang Sa flotilla
US regulator seeks US$5.3bil fine for Terraform Labs, Do Kwon
Straits Chinese eager for key role in 50th-anniversary celebration of Malaysia-China ties
Laos introduces new system to regulate foreign workers
Vietnam's economic growth forecast to reach 5.5% in 2024: World Bank

Others Also Read